H.B. Fuller Leverages Medical, Aerospace, and Pricing Trends Amid Volume Weakness

Zacks Investment Research··Read original
3▲2 ▼0Impact / 5
Summary · why it matters

H.B. Fuller is advancing its specialty materials strategy through deeper medical market exposure, strong aerospace and electronics demand, and pricing actions that offset inflation. The proposed acquisition of Advanced Medical Solutions would expand its total addressable market by $15 billion to $95 billion and supports a goal of exceeding 20% adjusted EBITDA margin by 2028. In Engineering Adhesives, organic growth was roughly 5% excluding the solar exit, with aerospace up 30% and electronics and general industries posting double-digit gains. Pricing increased net revenues by 3% in the fiscal second quarter, helping lift adjusted gross margin 200 basis points to 34.2% and adjusted EBITDA 9% to $181 million. However, volume remains a constraint, with flexible packaging soft, automotive down mid-single digits, and management guiding for low- to mid-single-digit volume declines in the second half. Shares have lost 7.2% year-to-date against a 15.7% rise for the industry.

Impact on assets 4

Materials▲ · 2 stocks
H B Fuller Company
FUL
▲ PositivePricingDemandrelevance

Pricing actions lifted adjusted gross margin 200 bps and adjusted EBITDA 9%

Aging Population▲ · 1 stocks
Artificial Intelligence▲ · 1 stocks